Found: 12
Select item for more details and to access through your institution.
TBA<sub>225</sub>, a fusion toxoid vaccine for protection and broad neutralization of staphylococcal superantigens.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-39890-z
- By:
- Publication type:
- Article
T-cell activation or tolerization: the Yin and Yang of bacterial superantigens.
- Published in:
- Frontiers in Microbiology, 2015, v. 6, p. 1, doi. 10.3389/fmicb.2015.01153
- By:
- Publication type:
- Article
CARD9-Dependent Neutrophil Recruitment Protects against Fungal Invasion of the Central Nervous System.
- Published in:
- PLoS Pathogens, 2015, v. 11, n. 12, p. 1, doi. 10.1371/journal.ppat.1005293
- By:
- Publication type:
- Article
Structurally Designed Attenuated Subunit Vaccines for <i>S. aureus</i> LukS-PV and LukF-PV Confer Protection in a Mouse Bacteremia Model.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0065384
- By:
- Publication type:
- Article
Novel Structurally Designed Vaccine for S. aureus α-Hemolysin: Protection against Bacteremia and Pneumonia.
- Published in:
- PLoS ONE, 2012, v. 7, n. 6, p. 1, doi. 10.1371/journal.pone.0038567
- By:
- Publication type:
- Article
Superantigen-presentation by rat major histocompatibility complex class II molecules RT1.B<sup>l</sup> and RT1.D<sup>l</sup>.
- Published in:
- Immunology, 2009, v. 128, n. 1pt2, p. e572, doi. 10.1111/j.1365-2567.2008.03033.x
- By:
- Publication type:
- Article
Dry and liquid formulations of IBT-V02, a novel multi-component toxoid vaccine, are effective against Staphylococcus aureus isolates from low-to-middle income countries.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1373367
- By:
- Publication type:
- Article
Rational Design of Toxoid Vaccine Candidates for Staphylococcus aureus Leukocidin AB (LukAB).
- Published in:
- Toxins, 2019, v. 11, n. 6, p. 339, doi. 10.3390/toxins11060339
- By:
- Publication type:
- Article
IBT-V02: A Multicomponent Toxoid Vaccine Protects Against Primary and Secondary Skin Infections Caused by Staphylococcus aureus.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.624310
- By:
- Publication type:
- Article
Safety and Immunogenicity of a 4-Component Toxoid-Based Staphylococcus aureus Vaccine in Rhesus Macaques.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.621754
- By:
- Publication type:
- Article
Lethal CD4 T Cell Responses Induced by Vaccination Against Staphylococcus aureus Bacteremia.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Lower Antibody Levels to Staphylococcus aureus Exotoxins Are Associated With Sepsis in Hospitalized Adults With Invasive S. aureus Infections.
- Published in:
- Journal of Infectious Diseases, 2012, v. 206, n. 6, p. 915, doi. 10.1093/infdis/jis462
- By:
- Publication type:
- Article